Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Comprehensive Income [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 82 $ 14,486,492 $ (13,878,553) $ (42,832) $ 565,189
Beginning balance, shares at Dec. 31, 2020 817,450        
Issuance of common related to offering $ 288 12,661,696 12,661,984
Issuance of common related to offering, shares 2,880,000        
Comprehensive loss (12,734) (12,734)
Net loss (2,261,536) (2,261,536)
Issuance common stock from convertible debt $ 135 1,644,132 1,644,267
Issuance common stock from convertible debt, shares 1,345,468        
Issuance of common for over-allotment $ 43 1,983,226 $ 1,983,269
Issuance of common for over-allotment, shares         432,000
Issuance of warrants for over-allotment 4,320 $ 4,320
Issuance of common stock from exercise warrant 5,000 $ 5,000
Issuance of common stock from exercise of warrant, shares         1,000
Issuance of common for services 14,200 $ 14,200
Issuance of common for services, shares         1,000
Beneficial conversion feature of convertible debt 340,420 $ 340,420
Ending balance, value at Jun. 30, 2021 $ 548 31,139,486 (16,140,089) (55,566) 14,944,379
Ending balance, shares at Jun. 30, 2021 5,476,918        
Beginning balance, value at Dec. 31, 2020 $ 82 14,486,492 (13,878,553) (42,832) 565,189
Beginning balance, shares at Dec. 31, 2020 817,450        
Ending balance, value at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236 17,530,819
Ending balance, shares at Dec. 31, 2021 7,053,146        
Beginning balance, value at Mar. 31, 2021 $ 124 15,299,161 (14,681,695) (41,221) 576,369
Beginning balance, shares at Mar. 31, 2021 1,236,887        
Issuance of common related to offering $ 288 12,661,696 12,661,984
Issuance of common related to offering, shares 2,880,000        
Comprehensive loss (14,345) (14,345)
Net loss (1,458,394) (1,458,394)
Issuance common stock from convertible debt $ 93 1,186,083 1,186,176
Issuance common stock from convertible debt, shares 927,031        
Issuance of common for over-allotment $ 43 1,983,226 $ 1,983,269
Issuance of common for over-allotment, shares         432,000
Issuance of warrants for over-allotment 4,320 $ 4,320
Issuance of common stock from exercise warrant 5,000 $ 5,000
Issuance of common stock from exercise of warrant, shares         1,000
Ending balance, value at Jun. 30, 2021 $ 548 31,139,486 (16,140,089) (55,566) $ 14,944,379
Ending balance, shares at Jun. 30, 2021 5,476,918        
Beginning balance, value at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236 17,530,819
Beginning balance, shares at Dec. 31, 2021 7,053,146        
Issuance of common related to offering $ 223 7,004,815 7,005,038
Issuance of common related to offering, shares 2,229,950        
Issuance of common related to restricted stock award $ 1 34,799 34,800
Issuance of common related to restricted stock award, shares 10,000        
Stock based compensation in relation to restricted stock award 654,246 654,246
Comprehensive loss (20,118) (20,118)
Net loss (2,505,944) (2,505,944)
Ending balance, value at Jun. 30, 2022 $ 929 47,206,953 (24,492,159) (16,882) 22,698,841
Ending balance, shares at Jun. 30, 2022 9,293,096        
Beginning balance, value at Mar. 31, 2022 $ 929 46,552,707 (22,836,298) (12,094) 23,705,244
Beginning balance, shares at Mar. 31, 2022 9,293,096        
Stock based compensation in relation to restricted stock award 654,246 654,246
Comprehensive loss (4,788) (4,788)
Net loss (1,655,861) (1,655,861)
Ending balance, value at Jun. 30, 2022 $ 929 $ 47,206,953 $ (24,492,159) $ (16,882) $ 22,698,841
Ending balance, shares at Jun. 30, 2022 9,293,096